Education
About Us
Working with TipRanks
Follow Us
Paradigm Biopharmaceuticals Ltd. (AU:PAR)
ASX:PAR
See the Price Targets and Ratings of:
PAR Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Bell Potter
AU$0.8
Buy
158.06%
Upside
Reiterated
02/03/25
Paradigm Biopharmaceuticals Ltd. (PBIGF) Receives a Buy from Bell Potter
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bell Potter
AU$0.8
Buy
158.06%
Upside
Reiterated
02/03/25
Paradigm Biopharmaceuticals Ltd. (PBIGF) Receives a Buy from Bell Potter
Best Analysts Covering Paradigm Biopharmaceuticals
Which Analyst Should I Follow If I Want to Buy AU:PAR and Sell After:
1 Month
xxx
Success Rate
4/7 ratings generated profit
Average Return
+1.59%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of +1.59% per trade.
3 Months
xxx
Success Rate
4/7 ratings generated profit
Average Return
+5.94%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +5.94% per trade.
1 Year
Success Rate
0/7 ratings generated profit
Average Return
-43.03%
reiterated a buy rating 3 months ago
Copying John Hester's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -43.03% per trade.
2 Years
xxx
Success Rate
0/7 ratings generated profit
Average Return
-73.31%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -73.31% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PAR Analyst Recommendation Trends
Rating
Jul 22
Oct 22
Dec 22
Apr 23
Feb 25
Strong Buy
3
3
3
3
3
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
3
3
3
Each month's total comprises the sum of three months' worth of ratings.
PAR Stock Forecast FAQ
What is AU:PAR’s average 12-month price target, according to analysts?
Based on analyst ratings, Paradigm Biopharmaceuticals Ltd.’s 12-month average price target is 0.79.
What is AU:PAR’s upside potential, based on the analysts’ average price target?
Paradigm Biopharmaceuticals Ltd. has 155.22% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Paradigm Biopharmaceuticals Ltd. a Buy, Sell or Hold?
Paradigm Biopharmaceuticals Ltd. has a consensus rating of Moderate Buy, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Paradigm Biopharmaceuticals Ltd.’s share price target?
The average share price target for Paradigm Biopharmaceuticals Ltd. is 0.79. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is AU$0.79 ,and the lowest forecast is AU$0.79. The average share price target represents 155.22% Increase from the current price of AU$0.31.
The highest analyst share price target is AU$0.79 ,and the lowest forecast is AU$0.79. The average share price target represents 155.22% Increase from the current price of AU$0.31.
What do analysts say about Paradigm Biopharmaceuticals Ltd.?
Paradigm Biopharmaceuticals Ltd.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Paradigm Biopharmaceuticals Ltd.?
To buy shares of AU:PAR, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.